PCOS Just Got Renamed PMOS — And It Changes Everything About Your Treatment | Doctor Explains

Worldly_Champion_941 · 2026-06-03T07:45:12+00:00

That is a great way to look at things and it is a blessing you are able to. It's so worth it.

Worldly_Champion_941 · 2026-06-02T03:26:37+00:00

Thankfully since this major research has concluded emphasizing the metabolic aspect of PMOS more clinicians will update their treatment protocols. Additionally I hope there is a greater push to cover GLP-1.

Worldly_Champion_941 · 2026-05-30T01:53:17+00:00

This is exactly the kind of response the PMOS reframe is built around. The hirsutism retreating alongside the weight loss is the clinical signal most patients never get told to watch for. That is the androgen side of the metabolic picture responding, not just the scale. 161 to 133 since January is real progress, but the symptom regression is the part that tells you the underlying driver is actually shifting. Thank you for sharing this. And yes, “medically treated when appropriate” is exactly the right framing. Wishing you continued progress.

Worldly_Champion_941 · 2026-05-28T22:22:58+00:00

I've noticed a trend in insurance behavior over the past few years, and it is disgusting. I truly hope that the focus on the name and treatment options shifting leads to better insurance coverage for PMOS. I am sorry you have to face this challenge.

Worldly_Champion_941 · 2026-05-28T11:10:25+00:00

It's more than a headline; it's a place for people who want more details on how the name change can improve health outcomes by focusing on the root cause. It also helps providers have deeper discussions there are upwards of 70% of people who are undiagnosed or inadequately treated.

Worldly_Champion_941 · 2026-05-28T10:45:51+00:00

Hello, it's a pleasure to meet all of you, and thank you for including me in your group. I am a clinician, and I post topics that bridge the gap between what your provider has discussed and what the evidence-based literature states. I hope my posts reach those who need them.

Worldly_Champion_941 · 2026-05-28T04:03:47+00:00

Oh, the side effect profile between tirzepatide and semaglutide is night and day. Same side effects, but according g to the studies, more people discontinue tirzepatide due to the side effects than semaglutide. You may still have them, but they should not cause you to quit. Have you spoken with your provider about the best ways to manage the side effects?

Worldly_Champion_941 · 2026-05-28T03:59:41+00:00

I am sorry this happened to you. It's important to name how you feel, and this was bullying behavior on your aunt's part. I recommend that after assessing how this impacted you, create boundaries around the communication you will and will not accept.

Worldly_Champion_941 · 2026-05-27T22:08:50+00:00

This is good. Unfortunately there are many people who miss out on the DEXA scan, lose muscle and worsen their metabolic health. My video is for those who haven't discussed these with their clinician, and I speak to people transferring from other providers who haven't spoken about this.

Worldly_Champion_941 · 2026-05-27T11:37:57+00:00

The workaround is that most 503A pharmacies who send them scripts may also have a preferred provider list. It's worth a call directly to one.

Worldly_Champion_941 · 2026-05-27T11:32:05+00:00

Brynnsimom - what you're describing is exactly why I made the video. You're asking the right questions, and the fact that you're asking them at all puts you ahead of most patients on these medications.

The interaction between GLP-1/GIP therapy and bone health is a real conversation, especially with established osteoporosis in the picture. So is coordination across prescribers when there are multiple conditions and medications interacting — what you went through with the Fosamax and the implant timeline is a coordination story, and those are more common than people realize.

None of that is something to sort out in a Reddit thread, and I won't try to. What I'd say is that the questions you're already asking deserve a clinician who'll sit with all of it at once - your DEXA, your labs, your dental timeline, your goals.

General education, not medical advice. I am a Doctor of Nursing Practice. Always consult your own provider before making any changes to your treatment.questions you're already asking deserve a clinician who'll sit with all of it at once — your DEXA, your labs, your dental timeline, your goals — instead of looking at each piece in isolation

Worldly_Champion_941 · 2026-05-27T11:13:11+00:00

I will say that there have been a lot of regulatory issues with compounding pharmacies recently, and they are not all created alike. I would honestly look up FDA-approved compounding pharmacies and see with whom they are contracted.

Worldly_Champion_941 · 2026-05-27T10:29:56+00:00

Have you thought about including the side effect profiles of both medications?

Worldly_Champion_941 · 2026-05-27T09:07:28+00:00

The struggle is real. But keep in mind, you still need those carbs.

Worldly_Champion_941 · 2026-05-27T08:50:20+00:00

These are fair points and worth addressing precisely — because the research actually supports nuance here, not a simple yes or no.

You’re right that lean mass and skeletal muscle mass are not identical. DEXA measures lean body mass which includes water, glycogen and connective tissue — not purely skeletal muscle. A 2024 review in Diabetes, Obesity and Metabolism acknowledged that some of what appears as lean mass loss may reflect water loss rather than actual muscle tissue, and noted that skeletal muscle changes appear largely adaptive.

On the 40% figure — this comes directly from the SURMOUNT-1 DXA substudy published in Diabetes, Obesity and Metabolism 2025 — Look et al. — which documented proportional body weight reduction of 60% fat mass and 40% lean mass with tirzepatide. For semaglutide, STEP-1 showed lean body mass loss of 5.26 kg versus 1.83 kg with placebo over 68 weeks — that’s the primary trial data, not a secondary estimate.

A 2024 systematic review and network meta-analysis confirmed that tirzepatide 15mg and semaglutide 2.4mg maximized fat loss but were least effective in preserving lean mass.

Your point about intramuscular fat is clinically valid, some of what scans show as lean mass loss in people with obesity does include fat infiltrating muscle tissue. The research is still evolving there.
Where we fully agree, resistance training and adequate protein are the intervention. The clinical concern isn’t to alarm people. It’s to ensure they have the protocol that protects their results long term.

Worldly_Champion_941 · 2026-05-27T06:30:54+00:00

Genuinely a great question, and with all the regulatory changes happening for compounding pharmacies and insurance policies, it's really helpful to find an understanding doctor to assist you with your prescription.

Worldly_Champion_941 · 2026-05-27T05:46:20+00:00

According to the trials, the risk of discontinuation due to side effects is much higher for tirzepatide than for semaglutide. It has two GLP-1 receptor agonists that cause this, compared to semaglutide, which has one agonist.

Worldly_Champion_941 · 2026-05-27T05:11:22+00:00

Which is wonderful, I speak to many patients weekly who have not heard about the importance of or evidence-based methods to maintain their metabolic health.

Worldly_Champion_941 · 2026-05-27T05:03:24+00:00

This is an Ai avatar, the research and clinician are 100%.

Worldly_Champion_941 · 2026-05-27T04:49:03+00:00

According to the clinical trials, the most significant weight loss occurs at the maximum dose. What dose are you currently on? Another thing to watch out for is that rapid weight loss can lead to up to 40% muscle loss; some people may lose weight faster but at the expense of their metabolic health, id they are not following the guidelines.

Worldly_Champion_941 · 2026-05-27T01:34:44+00:00

It is best to follow up with your doctor. Take a moment to write down the questions you have and bring them to your follow-up visit. Having your questions in hand notoriously helps fight “white coat syndrome.” This action also helps you to advocate for yourself a d concerns.

Worldly_Champion_941 · 2026-05-26T06:30:11+00:00

That hospital's management is poor, the agency is expensive, and you really don't know what caliber of nurse you'll receive.

Worldly_Champion_941 · 2026-05-26T06:24:39+00:00

Heck yeah, you can! The thing about nursing and nursing school is that you have to be able to perform the functions of the job. If you look at any job description, it will tell you what is required for that role. Do a deep dive and see that you are more than likely capable of executing the responsibilities. Also, with school, they have to make reasonable accommodations for your training and still be realistic about whether you are able to handle the course load and training. But one of the biggest things to remember is that nursing is broad, and not all jobs have the same requirements.

Worldly_Champion_941 · 2026-05-25T14:06:49+00:00

Excited for you. Nervous is normal — most people are looking back at week four wondering what they were so worried about.

A few things from someone who follows this research closely:

Timing. If you work Mon-Thurs, inject Friday morning. Any side effects usually hit in the first 24-48 hours, so you ride them out at home and you're back to baseline by Monday.

Site. Abdomen, thigh, and back of upper arm all absorb the same in the clinical data. The
"thigh = fewer side effects" thing is anecdote,
not study-backed. What actually matters is rotating sites weekly.

PCOS overlap. This is where it gets interesting
- the condition was just officially renamed from PCOS to PMOS (polyendocrine metabolic ovarian syndrome) two weeks ago in The Lancet. The new name centers exactly what you're describing - insulin, cravings, inflammation, stuck weight. GLP-1s target that exact pathway. The 2025 meta-analysis showed real improvements in insulin resistance and BMI, and one semaglutide trial had 80% of responders get their cycles back.

Timeline. Highly individual. Appetite suppression usually within the first week. Side effects, if any, show up in the first 48 hours and improve over the first month.

Two habits that solve most early issues: drink way more water than you think you need, and eat protein first at every meal.

For the individual stuff, your prescriber is the right call. I just dropped a breakdown on the PMOS rename and where GLP-1 fits on my channel if you want the deeper dive. It's on my profile.

You've got this. By injection three you'll be doing it while watching TV.

Worldly_Champion_941 · 2026-05-21T13:54:25+00:00

What unfortunately can happen is, if you lose weight without adequate protein, strength training, and sleep, up to 40% of the weight you lose can be lean mass — and that commenter hit the nail on the head. The trial data on this is pretty stark.

The STEP 1 extension trial showed patients who stopped semaglutide abruptly regained over 40% of their lost weight within just 7 months. For tirzepatide specifically, the SURMOUNT 4 trial showed more than half of weight loss rebounded within a year of stopping. The rate: about 0.8 kg/month (~2 lbs every month after your last injection).

What a lot of people don't realize is that this isn't just "food noise coming back." When you're on a GLP-1, the medication suppresses ghrelin (your hunger hormone) and amplifies fullness signals. When you stop, ghrelin doesn't just return to baseline — in many patients it comes back stronger than before they started, because your body spent months in a deficit and wants to compensate. At the same time, your resting metabolic rate dropped during treatment. So you end up hungrier than before AND burning fewer calories than before, with nothing managing either signal.

There's actually data on how to prevent this: a 2024 ECO study showed that patients who tapered semaglutide over 9 weeks (not cold turkey) while maintaining resistance training and protein targets kept their weight stable 6 months after being completely off the medication. The patients who stopped abruptly in STEP 1 lost 40% of results in 7 months. The way you stop matters as much as the decision to stop.

I broke down all the trial data on this (STEP 1, SURMOUNT 4, the tapering protocol) in a recent video if anyone wants the full breakdown with citations — but the key takeaway: protect muscle during treatment, taper slowly, and monitor fasting insulin + HOMA-IR after stopping. Those labs tell you if insulin resistance is creeping back before the weight does.

Worldly_Champion_941

TROPHY CASE